Epidemiology of<i>DSM-5</i>Drug Use Disorder

Grant, Bridget F.; Saha, Tulshi D.; Ruan, W. June; Goldstein, Risë B.; Chou, S. Patricia; Jung, Jeesun; Zhang, Haitao; Smith, Sharon; Pickering, Roger P.; Huang, Boji; Hasin, Deborah S.

doi:10.1001/jamapsychiatry.2015.2132

Cited by 694 publications

(344 citation statements)

References 49 publications

Supporting

Mentioning

295

Contrasting

Unclassified

Order By: Relevance

“…Reasons included that medical assistants did not offer the screen (e.g., were busy or staffing was low), patients did not speak/read English, or the primary care provider was behind schedule. The prevalence of cannabis and other substance use disorders in this study, based on documentation by clinicians in the EHR in the previous year, was low compared to US population estimates, 26,49 in contrast to rates for mental health diagnoses, 50 suggesting under-recognition of substance use disorders. Research is needed to determine whether routine assessment of cannabis and other drug use as part of behavioral health screening increases the prevalence of recognized substance use disorders.…”

Section: Discussioncontrasting

confidence: 67%

Frequency of Cannabis Use Among Primary Care Patients in Washington State

et al. 2017

View full text Add to dashboard Cite

Background and Objectives Over 12% of U.S. adults report past-year cannabis use, and among those who use daily, 25% or more have a cannabis use disorder. Use is increasing as legal access expands. Yet, cannabis use is not routinely assessed in primary care, and little is known about use among primary care patients and relevant demographic and behavioral health subgroups. This study describes the prevalence and frequency of past-year cannabis use among primary care patients assessed for use during a primary care visit. Methods This observational cohort study included adults who made a visit to primary care clinics with annual behavioral health screening, including a single-item question about frequency past-year cannabis use (March 2015-February 2016; n=29,857). Depression, alcohol and other drug use were also assessed by behavioral health screening. Screening results, tobacco use, and diagnoses for past-year behavioral health conditions (e.g., mental health and substance use disorders) were obtained from EHRs. Results Among patients who completed the cannabis use question (n=22,095; 74% of eligible patients), 15.3% (14.8–15.8%) reported any past-year use: 12.2% (11.8%–12.6%) less than daily and 3.1% (2.9%–3.3%) daily. Among 2,228 patients 18–29 years, 36.0% (34.0%–38.0%) reported any cannabis use and 8.1% (7.0%–9.3%) daily use. Daily cannabis use was common among men 18–29 who used tobacco or screened positive for depression: 25.5% (18.8%–32.1%) and 31.7% (23.3%–40.0%), respectively. Conclusions Cannabis use was common in adult primary care patients, especially among younger patients and those with behavioral health conditions. Results highlight the need for primary care approaches to address cannabis use.

show abstract

Section: Discussioncontrasting

confidence: 67%

Frequency of Cannabis Use Among Primary Care Patients in Washington State

et al. 2017

View full text Add to dashboard Cite

show abstract

“…For alcohol UD, community prevalence was 14% (53), whereas 19% is noted of this CNICS cohort. When drug-based UDs were aggregated across the four CNICS drug categories plus sedatives/tranquilizers, solvents/inhalants, hallucinogens, and club drugs, community prevalence was 4% (54). In the CNICS cohort—with measurement limited to cocaine, marijuana, methamphetamine, and opioids as well as a ‘past 90-day’ reporting interval (58)—29% prevalence is noted.…”

Section: Discussionmentioning

confidence: 99%

“…Alternative data sources, if generated via continuous and coordinated multisite collection, may address apparent gaps in extant literature to offer more comprehensive, detailed estimation of SUD prevalence. Patient geography and demography (i.e., age, gender, race/ethnicity, sexual identity) predict both substance use among HIV care enrollees (50–52) and SUD rates in community sampling (53, 54), and therby merit inclusion in such analytic work. The Center for AIDS Research Network of Integrated Clinical Systems (CNICS) (55) is a U.S.-based data source offering a multi-regional, continuous cohort of HIV care enrollees, with demographic information and capacity to delineate substance-specific SUDs.…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States

et al. 2016

View full text Add to dashboard Cite

Prior efforts to estimate U.S. prevalence of substance use disorders (SUDs) in HIV care have been undermined by caveats common to single-site trials. The current work reports on a cohort of 10,652 HIV-positive adults linked to care at seven sites, with available patient data including geography, demography, and risk factor indices, and with substance-specific SUDs identified via self-report instruments with validated diagnostic thresholds. Generalized estimating equations also tested patient indices as SUD predictors. Findings were: 1) a 48% SUD prevalence rate (between-site range of 21–71%), with 20% of the sample evidencing polysubstance use disorder; 2) substance-specific SUD rates of 31% for marijuana, 19% alcohol, 13% methamphetamine, 11% cocaine, and 4% opiate; and 3) emergence of younger age and male gender as robust SUD predictors. Findings suggest high rates at which SUDs occur among patients at these urban HIV care sites, detail substance-specific SUD rates, and identify at-risk patient subgroups.

show abstract

“…Also, various studies in other communities have shown these disorders (7)(8)(9)(10)(11)(12)(13)(14).…”

Section: Introductionmentioning

confidence: 95%

“…Among the reasons over the past few years in the field of clinical importance of mental disorders among substance abusers which presented, comorbidity of mental disorders is also an important factor in the etiology, prognosis and vulnerability of this group of patients (12,22).…”

Section: Introductionmentioning

confidence: 99%

Personality and Mental Disorders in Patients with Substance-Related Disorders Admitted to Addiction Clinics in Hamadan in 2014

Rahimi

Zarabian

Nazaribadie

et al. 2016

Avicenna J Neuro Psycho Physiology

View full text Add to dashboard Cite

Objectives: This study aimed to assess and compare the mental and personality disorders among people with substance-related disorder. Methods: This cross sectional study was performed from September 2014 to March 2015 in Hamadan city, Iran. The population of this study was all people who referred to the addiction clinics and were consumers of opioids or methamphetamine. Each client was examined in biaxial axis and patients with mental health were studied in the first axis using the SCID test. Also, in the second axis, the personality disorders were evaluated in the patients using the Minnesota multiphasic personality inventory (MMPI) test. Results:All the 103 patients participated in this study were males. The mean age of the patients was 9.13 ± 9.41 years. The results of the MMPI test revealed that schizoid, paranoid, and passive aggressive personality disorders were significantly higher in people with an opioid use disorder compared with the people who taking methamphetamine. However, an antisocial personality disorder in patients taking methamphetamine was more common than in patients who taking opioid. In patients taking opioids, based on the results of the SCID, depression with or without psychotic features, major depressive disorder (MDD) and panic disorder were significantly higher compared with patients taking methamphetamine. Conclusions: The Bipolar mood disorder, panic disorder, paranoid personality disorder, MDD with psychotic features and passive aggressive personality disorder were more prevalent in patient who taking opiate and the antisocial personality disorder, schizoid personality disorder, substance-induced mood disorder and somatoform disorder were more prevalent in patients taking methamphetamine.

show abstract

Epidemiology ofDSM-5Drug Use Disorder

Cited by 694 publications

References 49 publications

Frequency of Cannabis Use Among Primary Care Patients in Washington State

Frequency of Cannabis Use Among Primary Care Patients in Washington State

Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States

Personality and Mental Disorders in Patients with Substance-Related Disorders Admitted to Addiction Clinics in Hamadan in 2014

Contact Info

Product

Resources

About